Shenzhen Ionova Life Sciences Co., Ltd.
Clinical trials sponsored by Shenzhen Ionova Life Sciences Co., Ltd., explained in plain language.
-
New drug combo aims to shrink Hard-to-Treat tumors
Disease control Recruiting nowThis early-phase study tests a new drug called INV-1120, either by itself or combined with pembrolizumab (Keytruda), in adults with advanced solid tumors that have stopped responding to standard treatments. The main goals are to find safe doses and check for side effects. About 7…
Phase: PHASE1 • Sponsor: Shenzhen Ionova Life Sciences Co., Ltd. • Aim: Disease control
Last updated May 17, 2026 00:30 UTC
-
New hope for tough prostate cancer: experimental drug INV-9956 enters human trials
Disease control Recruiting nowThis study tests an experimental drug called INV-9956 in men with advanced prostate cancer that has spread and stopped responding to standard hormone therapy. The goal is to find a safe dose and see if the drug can shrink tumors or slow the cancer's growth. About 84 adult men wil…
Phase: PHASE1, PHASE2 • Sponsor: Shenzhen Ionova Life Sciences Co., Ltd. • Aim: Disease control
Last updated May 12, 2026 13:43 UTC